Effect of Different Approaches to Antimicrobial Therapy with Cefmetazole and Meropenem on the Time to Defervescence in Non-Severe Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> Bacteremia

Carbapenems are antimicrobial agents commonly used to treat extended-spectrum β-lactamase (ESBL)-producing bacteria. Although cefmetazole (CMZ) is considered effective for ESBL-producing <i>Escherichia coli</i> (ESBL-EC) bacteremia, previous studies showed its limitations, including the influence of...

Description complète

Détails bibliographiques

Auteurs principaux:	Takanobu Hoshi, Satoshi Fujii, Kei Watanabe, Yuta Fukumura, Koji Miyazaki, Madoka Takahashi, Sakae Taniguchi, Shingo Kimura, Arisa Saito, Naoki Wada, Masaji Saijo, Kazunori Yamada, Kuninori Iwayama, Marie Itaya, Hideki Sato
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-12-01
Collection:	Infectious Disease Reports
Sujets:	cefmetazole meropenem extended-spectrum β-lactamase <i>Escherichia coli</i> bacteremia
Accès en ligne:	https://www.mdpi.com/2036-7449/16/1/3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!